Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BLCO · against 202 other Healthcare companies of similar size
Ranked #115 of 203 · scores higher than 43% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 40–49, including BLCO · Click a bar to see the companies
A mix: stronger EBITDA yield and free cash flow yield, but weaker earnings yield than most Healthcare peers.
| Metric | BLCO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 200 reported | -1.6% | 2.4% | 23% | 30% | |
| EBITDA yieldHigher is better · 202 reported | 7.7% | 4.6% | 76% | 50% | |
| Free cash flow yieldHigher is better · 119 reported | 3.5% | 1.2% | 71% | 20% | |
| Book yieldHigher is better · 201 reported | 90.0% | 23.4% | 96% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 5 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 109 | 6.3B USD | 50 | 78 | |
| 113 | 4.0B USD | 49 | 46 | |
| 113 | 10.8B USD | 49 | 35 | |
| 115 | 34.2B CNY (≈$4.8B) | 48 | 59 | |
| 115 | 7.2B USD | 48 | 43 | |
| 115 | 12.3B USD | 48 | 35 | |
| 118 | 7.0B USD | 47 | 63 | |
| 118 | 596.9B INR (≈$7.2B) | 47 | 58 | |
| 120 | 5.76T KRW (≈$4.1B) | 46 | 59 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score